5 ' flanking variants of resistin are associated with obesity

Research output: Contribution to journalArticle

Abstract

Diabetes and obesity have long been known to be related. The recently characterized adipocyte hormone resistin (also called FIZZ3/ADSF) has been implicated as a molecular link between impaired glucose tolerance (IGT) and obesity in mice. A search for sequence variants at the human resistin locus identified nine single-nucleotide polymorphisms (SNPs) but no coding variants. An investigation into the association of these SNPs with diabetes and obesity revealed two 5' flanking variants (g.-537 and g.-420), in strong linkage disequilibrium, that are associated with BMI. In nondiabetic individuals from the Quebec City area and the Saguenay-Lac-St-Jean region of Quebec, the g.-537 mutation (allelic frequency = 0.04) was significantly associated with an increase in BMI (P = 0.03 and P = 0.01, respectively). When the data from these two populations were combined and adjusted for age and sex, both the g.-537 (odds ratio [OR] 2.72, 95% Cl 1.28-5.81) and the g.-420 variants (1.58, 1.06-2.35) were associated with an increased risk for a BMI greater than or equal to30 kg/m(2). In contrast, in case/control and family-based study populations from Scandinavia, we saw no effect on BMI with either of these promoter variants. No association was seen with diabetes in any of the population samples.

Details

Authors
  • JC Engert
  • MC Vohl
  • SM Williams
  • P Lepage
  • JC Loredo-Osti
  • J Faith
  • C Dore
  • Y Renaud
  • NP Burtt
  • A Villeneuve
  • JN Hirschhorn
  • D Altshuler
  • Leif Groop
  • JP Despres
  • D Gaudet
  • TJ Hudson
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Endocrinology and Diabetes
Original languageEnglish
Pages (from-to)1629-1634
JournalDiabetes
Volume51
Issue number5
Publication statusPublished - 2002
Publication categoryResearch
Peer-reviewedYes